Cargando…
Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220854/ http://dx.doi.org/10.1186/1471-2334-14-S2-O1 |
| _version_ | 1782342794252124160 |
|---|---|
| author | Mohamed, Sofiane Penaranda, Guillaume Gonzalez, Dimitri Camus, Claire Khiri, Hacène Boulmé, Ronan Sayada, Chalom Philibert, Patrick Olive, Daniel Halfon, Philippe |
| author_facet | Mohamed, Sofiane Penaranda, Guillaume Gonzalez, Dimitri Camus, Claire Khiri, Hacène Boulmé, Ronan Sayada, Chalom Philibert, Patrick Olive, Daniel Halfon, Philippe |
| author_sort | Mohamed, Sofiane |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4220854 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42208542014-11-10 Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure Mohamed, Sofiane Penaranda, Guillaume Gonzalez, Dimitri Camus, Claire Khiri, Hacène Boulmé, Ronan Sayada, Chalom Philibert, Patrick Olive, Daniel Halfon, Philippe BMC Infect Dis Oral Presentation BioMed Central 2014-05-23 /pmc/articles/PMC4220854/ http://dx.doi.org/10.1186/1471-2334-14-S2-O1 Text en Copyright © 2014 Mohamed et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Mohamed, Sofiane Penaranda, Guillaume Gonzalez, Dimitri Camus, Claire Khiri, Hacène Boulmé, Ronan Sayada, Chalom Philibert, Patrick Olive, Daniel Halfon, Philippe Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title | Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title_full | Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title_fullStr | Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title_full_unstemmed | Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title_short | Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure |
| title_sort | clinical impact of ultra deep versus sanger sequencing detection of minority mutations on hiv-1 drug resistance genotype interpretation after virological failure |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220854/ http://dx.doi.org/10.1186/1471-2334-14-S2-O1 |
| work_keys_str_mv | AT mohamedsofiane clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT penarandaguillaume clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT gonzalezdimitri clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT camusclaire clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT khirihacene clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT boulmeronan clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT sayadachalom clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT philibertpatrick clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT olivedaniel clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure AT halfonphilippe clinicalimpactofultradeepversussangersequencingdetectionofminoritymutationsonhiv1drugresistancegenotypeinterpretationaftervirologicalfailure |